Skip to content
10-Q

Quarterly Report

BIO-TECHNE Corp TECH

0001558370-24-014439

← back to feed
Filed
Nov 5, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · Oct 31, 2024 158.89M sh
Cash And Equivalents Q1 2025 · Sep 30, 2024 $187.54M
Cash And Equivalents Q1 2025 · Jun 30, 2024 $151.79M
Stockholders Equity Q1 2025 · Sep 30, 2024 $2.14B
Stockholders Equity Q1 2025 · Jun 30, 2024 $2.07B
Current Liabilities Q1 2025 · Sep 30, 2024 $142.13M
Current Liabilities Q1 2025 · Jun 30, 2024 $159.38M
Current Assets Q1 2025 · Sep 30, 2024 $648.57M
Current Assets Q1 2025 · Jun 30, 2024 $617.42M
Total Assets Q1 2025 · Sep 30, 2024 $2.74B
Total Assets Q1 2025 · Jun 30, 2024 $2.7B
Short Term Investments Q1 2025 · Jun 30, 2024 $1.07M
Shares Diluted Q1 2025 · Sep 30, 2023 161.94M sh
Dividends Paid Q1 2025 · Sep 30, 2023 $12.65M
Capex Q1 2025 · Sep 30, 2023 $13.59M
Operating Cash Flow Q1 2025 · Sep 30, 2023 $59.38M
Eps Diluted Q1 2025 · Sep 30, 2023 $0.31
Eps Basic Q1 2025 · Sep 30, 2023 $0.32
Sga Expense Q1 2025 · Sep 30, 2023 $105.33M
Net Income Q1 2025 · Sep 30, 2023 $50.99M
Operating Income Q1 2025 · Sep 30, 2023 $55.86M
Gross Profit Q1 2025 · Sep 30, 2023 $185.19M
Cost Of Revenue Q1 2025 · Sep 30, 2023 $91.74M
Revenue Q1 2025 · Sep 30, 2023 $276.94M